Total Payments
$764.54
2024 Payments
$764.54
Companies
22
Transactions
32
Payment Breakdown by Category
Food & Beverage$764.54 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $764.54 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $96.84 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90.62 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $57.93 | 2 | $0 (2024) |
| ABBVIE INC. | $51.67 | 2 | $0 (2024) |
| Incyte Corporation | $42.94 | 2 | $0 (2024) |
| PFIZER INC. | $37.93 | 2 | $0 (2024) |
| TerSera Therapeutics LLC | $34.55 | 1 | $0 (2024) |
| Eisai Inc. | $29.97 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $28.38 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $27.63 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $764.54 | 32 | AstraZeneca Pharmaceuticals LP ($96.84) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Rare Disease | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo, Tecentriq | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: BioOncology | ||||||
| 11/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Hematology/Oncology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Oncology | ||||||
| 10/25/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $27.21 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Oncology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Oncology | ||||||
| 10/07/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.98 | General |
| Category: Hematology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | Truxima (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Central Nervous System | ||||||
| 09/13/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 09/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Oncology | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.47 | General |
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Oncology | ||||||
| 08/19/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
About Dr. Sandra Kang, MD
Dr. Sandra Kang, MD is a Hematology & Oncology healthcare provider based in Jonesboro, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679005870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Kang, MD has received a total of $764.54 in payments from pharmaceutical and medical device companies, with $764.54 received in 2024. These payments were reported across 32 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($764.54).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Jonesboro, GA
- Active Since 03/28/2017
- Last Updated 09/06/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1679005870
Products in Payments
- KEYTRUDA (Biological) $57.93
- JAKAFI (Drug) $42.94
- Fabhalta (Drug) $37.01
- Zoladex (Drug) $34.55
- KISQALI (Drug) $33.25
- IMBRUVICA (Drug) $32.40
- Lenvima (Drug) $29.97
- DARZALEX (Biological) $28.38
- ULTOMIRIS (Biological) $27.63
- KRAZATI (Drug) $27.21
- REBLOZYL (Biological) $26.98
- Enhertu (Drug) $26.93
- TAGRISSO (Drug) $25.46
- CALQUENCE (Drug) $24.85
- IBRANCE (Drug) $24.35
- Onivyde (Drug) $24.07
- ENHERTU (Biological) $23.71
- Xospata (Drug) $23.65
- Itovebi (Biological) $23.19
- LYNPARZA (Drug) $22.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jonesboro
Mazen Khalil, M.d, M.D
Hematology & Oncology — Payments: $35,868
Hematology & Oncology $35,868
Carroll Scroggin, M.d, M.D
Hematology & Oncology — Payments: $5,714
Hematology & Oncology $5,714
Dr. Scott Dorroh, Md, MD
Hematology & Oncology — Payments: $5,326
Hematology & Oncology $5,326
David Nixon, M.d, M.D
Hematology & Oncology — Payments: $1,592
Hematology & Oncology $1,592
Michael Doherty, Md, MD
Hematology & Oncology — Payments: $443.65
Hematology & Oncology $443.65
Shefali Shah, Md, MD
Hematology & Oncology — Payments: $204.47
Hematology & Oncology $204.47